Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ketanserin for Raynaud's Phenomenon in Progressive Systemic Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433132/0/images/tooltip-triangle.png. Accessed 30 April 2024.
Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433132/0/images/tooltip-triangle.png. Accessed April 30, 2024.
Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433132/0/images/tooltip-triangle.png
Ketanserin for Raynaud's Phenomenon in Progressive Systemic Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433132/0/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
ID - 433132
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433132/0/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -